HCP

Clasado set to share prebiotic insight at ESPEN 2023

Clasado Biosciences (‘Clasado’) will be in attendance at the 45th European Society for Clinical Nutrition and Metabolism (ESPEN) Congress on Clinical Nutrition and Metabolism.

The highly anticipated event will be held from 11 – 14 September 2023 in Lyon, France. Nutrition experts from around the world will gather to explore the theme of ‘Live Healthy with Optimal Nutrition’, reflecting the event’s location.

The ESPEN Congress is a highly regarded platform that brings together healthcare professionals, researchers, academics and health industry leaders to exchange knowledge and insights on cutting-edge nutritional science, and further explore its inextricable links to health and well-being. By combining viewpoints and perspectives, the event aims to shed light on innovative approaches to nutritional care that have the potential to revolutionise health strategies worldwide.

As a company committed to advancing the potential of prebiotics, representatives from Clasado, including Dr. Lucien Harthoorn, R&D Director, and Dr. Frederic Narbel, VP of B2B Sales, will be engaging with delegates, and will share their expertise on the evolving role of prebiotics in contemporary health strategies.

“Attending the ESPEN Congress is an exciting opportunity to connect with like-minded professionals from around the world and explore the latest developments in nutritional innovation,” said Dr. Harthoorn.

“With gut health so prominent in today’s health and wellness discourse, we have a great deal of insight to share from our research on Bimuno® GOS – insight which will intrigue healthcare professionals and nutrition industry representatives alike. Forming one of the most comprehensive GOS research portfolios on the market, studies showcase the potential of Bimuno GOS in enhancing gastrointestinal health and immune function, as well as further afield in areas such as cognition and athletic health. As such, we are making great strides in expanding prebiotics outside of purely commercial nutraceuticals and exploring their potential in more direct health and medical applications.”

To schedule a meeting with the Clasado team during the 45th ESPEN Congress on Clinical Nutrition and Metabolism, please reach out to info@clasado.com.

For more information about the ESPEN Congress on Clinical Nutrition and Metabolism or to register for the event, visit https://espencongress.com.

To explore the scientific portfolio behind Bimuno® GOS and learn more about Clasado Biosciences, please visit www.clasado.com.